Celera Posts 13 Percent Decline in Q3 Revenues

Though its Berkeley HeartLab business continued to struggle, Celera CEO Kathy Ordoñez said the firm made progress in addressing some key issues affecting its financial performance.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.